Jonathan Hill, James Spratt, Charalambos Antoniades, et al

Watch time: 11h 6m 44s (20 videos)

About

Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).

Articles

Drug-eluting Balloons - The Next Sustainable Device Platform in Cardiovascular Disease?

Citation:

European Cardiology 2009;5(2):79–80

Low Revascularisation Rates and Relatively High Stent Thrombosis Rate After Implantation of Drug eluting Stents in High-risk Patients

Citation:

European Cardiovascular Disease 2007;3(1):92–4

Treatment of In-stent Restenosis - Past, Present and Future

Citation:

European Cardiology 2009;5(2):74–8

Percutaneous Heart Valve Therapy - Options, Risks and Benefits

Citation:

European Cardiology 2010;6(1):65–74